Diabetes, Metabolic Syndrome and Obesity (Jan 2021)
Progress of Clinical Trials for the Treatment of Gestational Diabetes Mellitus
Abstract
Tong Chen,1 Dan Liu,1 Xiaofeng Yao2 1Department of Endocrinology, First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, People’s Republic of China; 2Department of Preventive Medicine, Dalian Medical University, Dalian, Liaoning, People’s Republic of ChinaCorrespondence: Dan LiuDepartment of Endocrinology, First Affiliated Hospital of Dalian Medical University, Zhongshan Str. 222, Dalian 116011, People’s Republic of ChinaEmail [email protected] YaoDepartment of Preventive Medicine, Dalian Medical University, 9 W Lushun South Road, Dalian 116044, People’s Republic of ChinaEmail [email protected]: Gestational diabetes mellitus (GDM) is one of the most common and severe complications of pregnancy, which is not only associated with perinatal complications but also has a long-term adverse effect on maternal and their offsprings. At present, the treatment of GDM focuses on the control of maternal blood glucose. Although lifestyle changes, hypoglycemic drugs, blood glucose monitoring, and other medicines that can improve maternal blood glucose to a certain extent, there are still some patients affected and have adverse pregnancy outcomes. The prevention of GDM and the treatment of improving pregnancy outcomes are urgently needed. This review summarized recently published clinical trials related with the treatment of GDM, aiming to provide additional options for the treatment of GDM.Keywords: gestational diabetes mellitus, clinical trials, review
